ArticleFrontiers in cell and developmental biology2025
Molecular signatures of preeclampsia subtypes determined through integrated weighted gene co-expression network analysis and differential gene expression analysis of placental transcriptomics.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Determinants of Placental Versus Maternal Preeclampsia.Hypertension (Dallas, Tex. : 1979) · 2026Article
- First-trimester adipocytokine levels as predictive biomarkers for preeclampsia: a prospective case-control study.European journal of medical research · 2026Article
- Tailoring low-dose aspirin to prevent preeclampsia: translational and biomarker insights.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preeclampsia (PE) is a multisystemic pregnancy syndrome that presents in different clinical subtypes. While placental dysfunction is a critical feature of PE, its contribution to different PE subtypes remains unclear. This study aims to use integrated bioinformatics analysis of placental transcriptomics to investigate subtype-specific molecular mechanisms associated with PE. Methods: A systematic search of the Gene Expression Omnibus (GEO) repository identified two datasets (GSE234729, n = 123; GSE75010, n = 157) for integrated Weighted Gene Co-expression Network Analysis (WGCNA) and differential gene expression analysis. We constructed co-expression networks and identified gene modules correlated with three PE subtypes (severe, early-onset and late-onset). Differential gene expression analysis was conducted using the "limma" R package. Differentially expressed genes (DEGs) overlapping with PE subtype-correlated WGCNA modules underwent Gene Ontology (GO) enrichment analysis. Consistently dysregulated genes were validated in an additional external dataset (GSE25906) and RT-PCR analysis of placental samples from 21 PE cases and 21 uncomplicated controls. Results: We identified distinct molecular signatures associated with each PE subtype. The green gene module was positively correlated with severe PE (r = 0.63, p = 4e-15), containing 179 DEGs primarily involved in lipid metabolism and hypoxia response processes. Early-onset PE had two highly significant gene modules: the yellow module (r = 0.73, p = 4e-15) with 112 DEGs enriched in biological processes related to gonadotrophin secretion and lipid storage, and the black module (r = -0.55, p = 5e-08) with 47 DEGs significantly enriched in chronic inflammation responses. Late-onset PE showed moderate correlation with the ivory module (r = 0.46, p = 5e-05), containing 23 DEGs enriched in p38MAPK stress-response signalling. Cross-subtype analysis identified 20 consistently dysregulated genes across three PE subtypes, with four upregulated genes ( Conclusion: Though placental dysfunction occurs across all subtypes with a core set of upregulated genes, variation exits in placental gene expression patterns among PE subtypes. Severe and early-onset PE exhibit large molecular perturbations, while late-onset PE presents more subtle alterations. Aberrant placental lipid storage may contribute to disease severity and early manifestation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.